Unveiling the non-repair face of the Base Excision Repair pathway in RNA processing: A missing link between DNA repair and gene expression? by Antoniali, Giulia et al.
Contents lists available at ScienceDirect
DNA Repair
journal homepage: www.elsevier.com/locate/dnarepair
Unveiling the non-repair face of the Base Excision Repair pathway in RNA
processing: A missing link between DNA repair and gene expression?
Giulia Antoniali, Matilde Clarissa Malfatti, Gianluca Tell⁎
Laboratory of Molecular Biology and DNA repair, Department of Medicine University of Udine, 33100 Udine, Italy








A B S T R A C T
The Base Excision Repair (BER) pathway, initially studied as a mere DNA repair pathway, has been later found to
be implicated in the expression of cancer related genes in human. For several years, this intricate involvement in
apparently diﬀerent processes represented a mystery, which we now are starting to unveil.
The BER handles simple alkylation and oxidative lesions arising from both endogenous and exogenous
sources, including cancer therapy agents. Surprisingly, BER pathway involvement in transcriptional regulation,
immunoglobulin variability and switch recombination, RNA metabolism and nucleolar function is astonishingly
consolidating. An emerging evidence in tumor biology is that RNA processing pathways participate in DNA
Damage Response (DDR) and that defects in these regulatory connections are associated with genomic instability
of cancers. In fact, many BER proteins are associated with those involved in RNA metabolism, ncRNA processing
and transcriptional regulation, including within the nucleolus, proving a substantial role of the interactome
network in determining their non-canonical functions in tumor cells. Maybe these new insights of BER enzymes,
along with their emerging function in RNA-decay, may explain BER essential role in tumor development and
chemoresistance and may explain the long-time mystery. Here, we would like to summarize diﬀerent roles of
BER pathway in human cells. First, we will give a short description of the classical BER pathway, which has been
covered in detail in recent reviews. We will then outline potential new roles of BER in gene expression and RNA
metabolism. Although recent works have provided tremendous amount of data in this ﬁeld, there are still lot of
open questions.
1. Relevance of the canonical BER pathway and open questions
The BER pathway (Fig. 1) is an essential DNA repair system in
higher eukaryotes and gene deletions of the core BER factors (apurinic/
apyrimidinic endonuclease 1 – APE1, DNA polymerase β− Polβ, X-ray
repair cross-complementing 1 – XRCC1, DNA ligase I − LigI and DNA
ligase III− LigIII) results in embryonic or early post-natal lethality [1].
The pathway is comprised of ﬁve major steps, in which enzymatic and
non-enzymatic components cooperate to carry out a highly integrated
set of reactions: i) recognition and excision of the damaged base; ii)
incision of the resulting AP site to generate a nick on the DNA back-
bone; iii) processing of the nick ends; iv) ﬁlling of the nucleotide gap;
and v) sealing of the nick (Fig. 2).
Diﬀerent speciﬁc DNA glycosylases scan the DNA substrate, re-
cognize, through a ﬂipping out mechanism, and excise the damaged
base in a lesion-speciﬁc manner. Two kinds of DNA glycosylases are
known: mono- or bi-functional, depending on their mechanism of ac-
tion. While monofunctional DNA glycosylases (e.g. the uracil-DNA
glycosylase − UNG) simply cleave the C1′-N-glycosidic bond, gen-
erating an AP-site, bifunctional enzymes also possess an associated β-
lyase activity (e.g. the 8-oxoguanine DNA glycosylase − OGG1) de-
puted to cleave the DNA backbone leaving a 3′-α,β-unsaturated alde-
hyde blocking group. An additional family of DNA glycosylases, re-
presented by the human NEIL1 and NEIL2 enzymes, is also able to
operate a β,δ-elimination reaction, leaving a 3′-phosphate nick [2].
Higher eukaryotes are provided with a vast array of DNA glycosylases
with a signiﬁcant redundancy in their damage selectivity for this
reason, single knockout of several DNA glycosylases is not lethal per se,
although an accumulation of unrepaired DNA lesions occurs [3].
The glycosylase-catalyzed reaction generally produces an AP-site,
which is immediately processed by APE1 in metazoans. APE1 cleaves at
the 5′ termini of the abasic site, generating a nick on the DNA backbone
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and producing a 3′-OH and a 5′-dRP (deoxyribonucleotide-phosphate)
termini. Usually, APE1-incision activity is suﬃcient to generate the
DNA ends required for the completion of the DNA repair process. Once
further oxidation of the DNA termini or base-excision operated by bi-
functional glycosylases occurs, other end-processing enzymes may be
involved, such as tyrosyl-DNA phosphodiesterase 1 (TDP1), aprataxin
(APTX) or polynucleotide kinase 3′-phosphatase (PNKP). The dRP-lyase
activity of Polβ, along with APE1 3′-phosphodiesterase activity, con-
tributes to the “end-cleaning” process, ultimately generating a single-
nucleotide gap that can be eﬃciently ﬁlled in and re-ligated [4].
BER is then completed via a “short-patch” (SP) or a “long-patch”
(LP) pathways, depending on the 5′-moiety generated. In the SP-BER,
Polβ is engaged to replace the missing nucleotide, and then is followed
by the XRCC1-LigIII complex, which is responsible for the ligation of
the nick [5]. In the presence of a 5′-moiety refractory to the Polβ lyase
activity, low ligation eﬃciency, or during the S-phase of the cell cycle
(i.e. when replication-associated proteins are more abundant), BER can
be completed through the LP-BER which involves a strand displace-
ment-dependent gap ﬁlling process [1]. Replicating polymerases, such
as DNA polymerase δ and ε, act in concert with the sliding clamp PCNA
(proliferating cell nuclear antigen) in the LP-BER, generating a stretch
of 2–12 nucleotides, which is removed by the ﬂap endonuclease 1
(FEN1). Finally, intervention of the PCNA-associated DNA Ligase I seals
the nick [6].
Notably, BER protein components are involved in at least two sub-
pathways, namely Single Strand Break Repair (SSBR) and Nucleotide
Incision Repair (NIR) [7]. SSBs are generated by diﬀerent sources in-
cluding reactive oxygen species (ROS), radiomimetic drugs, ionizing
radiation, topoisomerase-mediated DNA cleavage or they are un-
avoidable intermediates generated during BER processing. The SSBR
pathway initiates through recruitment of the poly(ADP-ribose) poly-
merase PARP1, which recognizes exposed SSBs and modulates the re-
pair process through enzymatic ADP-ribosylation of protein substrates.
Tight connection between BER and SSBR has been highlighted by the
observation that many BER proteins (e.g. XRCC1, Polβ) interact with
PARP1 [6] and by the fact that PARP1 has been shown to orchestrate
the BER processing of uracil and AP-sites [8]. Interestingly, it has been
recently demonstrated that APE1 has glycosylase-independent NIR ac-
tivity on particular modiﬁed bases, see below. Although very intri-
guing, the physiological impact of the NIR pathway is still under in-
vestigation, as within the intracellular milieu the presence of speciﬁc
DNA glycosylases would likely dampen the eﬃciency of the NIR process
on DNA.
Overall, BER is currently regarded as a dynamic intertwining of
diﬀerent enzymes and auxiliary proteins that operate in a highly co-
ordinated manner to allow temporal and spatial modulation. The re-
levance of this coordination is remarked by several observations, which
still deserve further studies:
• imbalanced expression of BER components has been linked to
genomic instability. In particular, overexpression of core elements of
the pathway is a hallmark of cancer progression and resistance to
therapy. Increased expression of a single BER factor may result in
competition or in excessive enzymatic activity, which is not com-
pensated by equimolar amounts of other BER proteins. This has been
formally demonstrated, in the case of APE1 [9–11] and Polβ [12].
• abortive intermediates of the pathway are intrinsically cytotoxic
since unprotected intermediates (e.g. SSBs) are much more toxic
than the initial damaged base [13]. Therefore, the ﬁne-tuning and
coordination of the pathway is possibly the result of an evolutionary
tradeoﬀ between the rapid repair of mutagenic lesions and the po-
tentially hazardous intermediates that such repair may generate.
In order to explain mechanisms evolved to optimize the repair ef-
ﬁciency of the BER pathway, several models have been proposed in-
cluding those of the ‘passing the baton’ and the ‘BERosome’ [7,8,14].
Despite the apparent divergence amongst models that have been put
forward to explain the complexity of BER, each of them probably de-
scribes diﬀerent aspects of a unique and highly dynamic integrated
process. However, it is clear how it is modulated through a complex
network of more or less stable DNA-mediated or protein-protein inter-
actions, among BER enzymes and non-enzymatic scaﬀold proteins (e.g.
XRCC1, PCNA) and PTMs (Post-translational modiﬁcations). Phos-
phorylation, acetylation, methylation, SUMOylation, as well as ubi-
quitination of almost every BER component have been suggested to
play a role in the modulation of the pathway [7].
An emerging concept in this ﬁeld is the role of some non-canonical
regulatory proteins as BER modulators. Several proteins, apparently
unrelated to the pathway, have recently been discovered as novel un-
expected coordinators of BER [15]. p53, for instance, has been im-
plicated in the modulation of both APE1 and Polβ [6], whereas our
laboratory discovered nucleophosmin (NPM1) as a modulator of the
APE1 enzymatic activity [16]. Additional regulation of the BER
pathway is also achieved through evolutionarily acquired disordered
extensions of some BER components [17,18]. These accessory proteins
were proposed to be important for stabilizing large complexes, “re-
pairsome”, by providing extended interaction surface area [19].
An interesting link between DNA damage sensing and modulation of
BER protein amount has been recently demonstrated. Indeed, BER
proteins amount, which is generally abundant with a relatively long
half-life, is constantly oscillating in response to the DNA damage load at
the steady-state level. This equilibrium is strictly controlled by the
ubiquitin-proteasome system [4]. It is possible that the high level of
them (such as APE1 and Polβ) observed in several tumors is the result of
perturbations of this equilibrium. Understanding these aspects will shed
light on the role of BER proteins in cancer development.
2. NIR activity of APE1 on non-canonical substrates
In the last decade, Nucleotide Incision Repair (NIR) pathway has
been described as a new function of APE1 which works as back up of
BER pathway ensuring a correct removal of damaged bases as a result of
oxidative stress [20–25]. NIR activity by APE1 consists of an incision at










Fig. 1. BER exerts diﬀerent functions in human cells.
Schematic representation of diﬀerent biological functions of Base Excision Repair (BER)
pathway in human cells including DNA repair player of alkylated and oxidative DNA
lesions; regulator of expression of genes involved in response to genotoxicants; regulator
in RNA metabolism, control of nucleolar function and regulation of immunoglobulin Class
Switching together with AID.
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the 5′ next to a oxidatively damaged base in a DNA glycosylase–inde-
pendent manner, providing a proper 3′-OH group for further processing
[20]. After the removal of the dangling damaged nucleotide by a ﬂap
endonuclease [26,27], DNA backbone can be eﬃciently repaired by a
DNA polymerase. In this way, the NIR action avoids the generation of
potentially toxic AP-intermediates [28]. Several uncanonical substrates
are processed by APE1 through NIR activity, including 5,6-dihydro-2′-
deoxyuridine (DHU) [20,28], 5,6-dihydrothymidine (DHT) [20,28], 5-
hydroxy-2′-deoxyuridine (5OHU) [20,28], 5-hydroxy-2′-deoxycitidine
(5OHC) alpha-2′-deoxynucleosides (αdA, αdT and αdC) [20,28–31],
the majority of which are generated under ionizing radiation (IR) and
exposure to certain drugs. This non-canonical activity of APE1 could
explain how, on the contrary to what is observed in APE1 deﬁcient cells
[32–34], the lack of DNA glycosylases does not sensitize cells or mice to
oxidative agents and IR [35–37]. Although NIR pathway plays an im-
portant role as a back-up of BER, experimental working conditions,
such as salts and pH conditions, seem to aﬀect the NIR function of
APE1. The optimal conditions for NIR activity are very similar to those
required for the 3′–>5′ exonuclease activity by APE1, characterized by
a pH around 6.4–6.8, and a KCl concentration of 50 mM [20]. More-
over, NIR is more active to 100-fold lower MgCl2 concentration com-
pared to that of the canonical AP-endonuclease activity [20]. Interest-
ingly, the N-terminal domain of APE1 deputed to modulate protein-
protein interaction and indispensable to redox activity but not AP-
endonuclease activity [38], is contrarily essential for the NIR activity;
indeed the lack of the ﬁrst 33 N-terminal aminoacids of the protein
produces a 20-fold-decrease of APE1 NIR activity [20]. Moreover, Ti-
mofeyeva et al. demonstrated that Lysine in position 98 contributes
signiﬁcantly in the 5′-phospodiester bond hydrolysis of DNA substrate,
but not in the dissociation of the enzyme-product complex [21]. In-
terestingly, the substitution of this amino acid inﬂuences the APE1 NIR
activity more than BER, demonstrating that the APE1 active site in-
volved in NIR and BER pathways is the same, but diﬀerent conforma-
tional requirements are responsible for APE1 NIR or BER activities [21].
3. Unusual involvement of BER enzymes in the regulation of gene
expression
Generation of single base modiﬁcations is not only a harmful DNA
modiﬁcation caused by genotoxic agents but it may have important
regulatory functions also at the basis of epigenetic mechanisms. For
instance, 5-methylcytosine and Uracil, which are enzymatically gener-
ated during epigenetic regulation of gene expression and in antibody
diversiﬁcation processes, respectively, are the most well-known ex-
amples of this phenomenon. Very recently, a number of studies pointed
to 8-oxoG (8-oxo-7,8-dihydroguanine) modiﬁcation as a new epigenetic
mark with a relevant role in the control of gene expression [39]. Gen-
eration of 8-oxoG on diﬀerent promoters regulates the activity of
Fig. 2. Schematic representation of consecutive BER
steps during the repair of diﬀerent DNA lesions.
BER is endowed to repair diﬀerent lesions including
modiﬁed dNMPs (blue star) and modiﬁed rNMPs
(red star). Diﬀerent types of mono- and bi- functional
glycosylases exist in order to recognize damaged
dNMPs, such as oxidized dNMPs, uracil, etc., and
generate deoxy-abasic sites, which are subsequently
processed by APE1. At the same way, an oxidized
rNMPs, embedded in DNA, could be recognized by
speciﬁc glycosylases such as YB-1 and NEIL1, and be
converted in ribo-abasic sites, eﬃciently processed
by APE1. For both types of damages, APE1 possesses
a NIR activity in which APE1 cleaves directly the
lesion bypassing the glycosylases action. BER
pathway is ﬁnally terminated by diﬀerent speciﬁc
enzymes depending on whether the Short Patch or
Long Patch pathways.
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several transcription factors (e.g. Hif1α, STAT1, NF-κB and MYC) in
conjunction with OGG1 protein and, in turn, regulates the expression of
important genes involved in cancer development, such as VEGF [40],
SIRT-1 [41] and inﬂammatory genes such as TNF-α and CXCL2 [42].
Interestingly, this last role of OGG1 on inﬂammatory genes may explain
the reduced inﬂammatory response in Ogg1−/− mice [43].
Canonical epigenetic mechanisms seem to crosstalk with new DNA
damage epigenetic marks. In fact, it has been recently shown that de-
methylation of histone H3 at Lys9 by LSD1 de-methylase, through
generation of H2O2, promotes oxidation of estrogen-receptor responsive
promoters in breast cancer cell lines with a consequent OGG1-depen-
dent promoter activation [44]. In a similar way, also Myc-induced,
retinoic acid-induced and androgen receptor-induced transcription has
been proved [45–47] demonstrating that the transcriptional function of
OGG1 is a much more general non canonical function than previously
thought. OGG1, in complex with 8-oxoG free base, has been recently
suggested to play a role in signal transduction as a new Guanine Ex-
change Factor (GEF) for Ras, Rac and Rho GTPases [48–50]. These
ﬁndings open new completely unpredicted perspectives for this unusual
DNA-repair enzyme in controlling gene expression.
Another well-known enzyme of the BER pathway having important
function in transcriptional regulations is APE1 [11,51]. APE1 plays a
role in the regulation of expression of human genes during oxidative
stress conditions and it is important for cancer biology, through in-
direct- and direct-mechanisms [52]. Thus, besides providing a crucial
role in the genome stability maintenance, APE1 acts also as a master
regulator of cellular response to genotoxic damage via indirect me-
chanisms. Indeed, by regulating the expression of several tumor related
genes, through the stimulation of DNA binding activity of transcription
factors such as NF-ĸB, Egr-1, Hif-1α, Nrf1, APE1 can inﬂuence the onset
of inﬂammatory and metastatic progression [11]. Through the redox-
mediated activation of NF-ĸB and Hif1α, for example, APE1 indirectly
drives IL-8 and VEGF expression, respectively, thus acting as a key
regulator of inﬂammatory and tumor-associated neo-angiogenesis pro-
cesses. Moreover, APE1 has been implicated in chemoresistance, con-
sidering its ability to stimulate the expression of the multi-drug re-
sistance gene MDR1 through the interaction with Y-box-binding protein
1 (YB-1) [53], and its regulatory abilities on the PTEN tumor suppressor
[54,55]. We recently characterized a direct role of APE1 in the tran-
scription of SIRT1 gene through the binding of nCaRE-sequences pre-
sent on its promoter, demonstrating that BER-mediated DNA repair
promotes the initiation of transcription of SIRT1 gene upon oxidative
DNA damage [41]. A recently published paper gave a deﬁnitive prove
to our previous ﬁndings and suggested a novel role of APE1 in epige-
netic regulation, through modulating in a redox-mediated manner the
DNMT1 expression and causing consequent suppression of Oct4 and
Nanog expression through speciﬁc promoter methylation [56]. The
epigenetic role of 8-oxoG modiﬁcation was further supported by a re-
cent publication showing a regulatory function of BER enzymes on
speciﬁc gene expression by controlling the topological superstructure of
G-quadruplex containing promoters, such as those of VEGF and NTHL1
genes [57], as also discussed in another article of this issue by A.
Fleming and C. Burrows. All these studies highlight a new unsuspected
function of oxidative DNA lesions as novel epigenetic mechanisms of
gene regulation through the action of BER enzymes.
Moreover, despite the previous consistent research into APE1
Fig. 3. APE1 protein interactors are highly inter-
connected.
The top four functional annotation clusters of APE1
interactors identiﬁed by DAVID enrichment analysis
based on gene ontology terms of biological processes.
Protein interactors that are found in more than one
cluster are colored accordingly.
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molecular mechanisms in DNA damage repair, only recently it has been
hypothesized that this protein may play an unsuspected though im-
portant function in RNA metabolism impacting on the post-transcrip-
tional control of gene expression [17,58,59].
Overall, these pioneering studies hold the promise to change the
focus of scientiﬁc research from investigating the canonical roles of BER
enzymes in DNA repair to the study of their function in gene regulation
highlighting the BER peculiarity for eukaryotic cells. Overall, these
studies will contribute to open the DNA repair world to RNA universe.
4. BER enzymes and RNA metabolism: unexpected ﬁndings from
interactomics studies
Emerging evidences have pointed out that DNA damage repair and
RNA metabolism are more closely related than previously thought. In
addition, ncRNAs and miRNAs act at multiple levels of DNA damage
response regulation and have been proposed as novel anticancer ther-
apeutic targets [59]. DNA repair enzymes, in particular a large cohort
of BER proteins, have been implicated in RNA metabolism and in
transcriptional regulation of genes suggesting that DNA damage repair
and RNA pathways are tightly inter-regulated [59].
A number of recent interactomic studies signiﬁcantly contributed to
open new scenarios for the comprehension of non-canonical functions
of BER proteins, including understanding their unusual distribution in
the nucleolar compartment [17,60,61] (Antoniali et al., submitted). The
APE1-interactome network, characterized in part in our laboratory and
in diﬀerent literature works, actually comprises more than 100 diﬀerent
protein species whose functions are related to four biological pathways
intimately interconnected: DNA repair, Excision Repair, RNA proces-
sing and Transcriptional Regulation (Fig. 3).
Actually, the major focus is on APE1, SMUG1 and PARP1, as pro-
totypical examples [17,59,62–64]. In this review, in particular, we
highlight current knowledge of APE1 in controlling RNA metabolism.
Interested readers are referred to the aforementioned references for
further details about SMUG1 and PARP1.
5. BER enzymes and miRNA regulation: a new paradigm in gene
expression?
We recently found that many ncRNAs, few miRNAs and some
functional RNAs are directly bound by APE1 in cancer cells (Antoniali
et al., submitted). Furthermore, preliminary analysis from our labora-
tory indicated a potential role of APE1 in miRNA biology through an
eﬀect on the Microprocessor complex. These observations prompt a
new model that links DNA damage responses and the modulation of
target genes, and highlight how APE1 may regulate gene expression
through its direct binding and/or processing of speciﬁc RNA. Therefore,
studying APE1 new function in miRNAs processing may represent a
novel ﬁeld of investigation in cancer biology, which may be linked to its
role during cancer progression.
MicroRNAs (miRNAs) are small non-coding RNA that function as a
guide in RNA silencing of most protein-coding transcripts thereby being
critical regulators of nearly all physiological and pathological pro-
cesses. As a consequence, a delicate temporal/spatial balance between
miRNAs and their targets is central to achieve the appropriate biolo-
gical outcome and, it is not surprising, that any deregulations of miRNA
biogenesis and expression have been linked to a broad spectra of pa-
thological features of human diseases including cancer [65]. Under-
standing whether APE1 regulation of target genes of genotoxic re-
sponse, could be mediated through miRNA processing will deﬁnitively
increase our knowledge regarding its role in tumor progression and
chemoresistance.
An increasing number of evidences indicate that miRNA post-tran-
scriptional maturation, rather than transcription, is often perturbed in
cancer. The accumulation of miRNAs precursor forms and the corre-
sponding depletion of mature forms have been evidenced in human
cancers compared to normal tissue [66], strongly indicating that the
impairment of key steps in miRNA biogenesis could be the underlying
cause. RNA binding proteins (RBPs) are crucial components in the de-
termination of miRNA function and stability, as they control diﬀerent
steps of miRNA biogenesis, localization, degradation and activity.
Mechanisms regulating mammalian miRNA biogenesis are quite
complex and comprise a series of biochemical steps converting a pri-
mary miRNA transcript (pri-miRNA) into a biologically active mature
form [65,67]. The canonical miRNA biogenesis pathway is character-
ized by two subsequent ribonuclease reaction steps. First, in the nu-
cleus, where the transcription by RNA polymerase II takes place, pri-
miRNAs are recognized and cropped into hairpin-structure precursors
(pre-miRNAs) by the Microprocessor complex minimally composed by
the nuclear RNase III Drosha and the RNA binding protein DGCR8
(DiGeorge critical region 8)[68]. Subsequently, pre-miRNAs are ac-
tively exported by Exoportin-5 in the presence of its Ran-GTP co-factor
into the cytoplasm [69] where a second-round ribonuclease reaction
mediated by another RNase III enzyme, Dicer, generates a mature
∼22nt duplex miRNA [70]. Only one strand of this miRNA duplex is
loaded onto the RNA-induced silencing complex (RISC) whereas the
other is usually degraded. Mature miRNAs function as guides by base
pairing the RISC complex to its target mRNAs, whereas the Argonaute
(Ago) family proteins serve as eﬀectors by recruiting factors that induce
translational repression, mRNA deadenylation and mRNA decay [71].
In the last decade, as scientists began to characterize a larger frac-
tion of miRNA genes, it appeared that the complexity and pleotropic
nature of miRNAs have been underestimated [72]. The multiple steps of
miRNA maturation could potentially provide a variety of molecular
options revealing a complex dynamic in miRNA processing. Recent
studies have pointed out alternative pathways for maturation of certain
miRNAs that deviate from the canonical miRNA biogenesis pathway
bypassing one of the RNase III cleavage steps [72–74]. This is the case
of the mirtrons, pre-miRNA hairpins generated by splicing and deb-
ranching of short hairpin introns, and other small nucleolar RNAs
(snoRNAs), transfer RNAs (tRNAs), tailed endogenous shRNA, long
hairpin RNAs (hp-RNAs) derived from short interspersed nuclear ele-
ments (SINEs) that bypass the cleavage step of Drosha [75–77]. To date,
miR-451, an erythropoietic miRNA conserved in vertebrates, is instead
the only Dicer-independent miRNA identiﬁed [78].
Furthermore, there is still a great uncertainty regarding the exact
composition of the miRNA-processing complex. Although the core
components, Drosha and DGCR8 are required for the biogenesis of al-
most all miRNAs, the Drosha complex contains numerous auxiliary
factors including the DEAD-box RNA helicase p68 (DDX5) and p72/p82
(DDX17) which selectively promote the activity of Drosha processing
over certain pri-miRNAs. Dicer is instead associated with TAR RNA-
binding protein (TRBP) and the kinase R-activating protein (PACT)
[67]. Several studies have further revealed a number of further RNA
binding proteins that are required for miRNA biogenesis. These mod-
ulators have been shown to positively or negatively regulate miRNA
biosynthesis by directly binding miRNA terminal loop region, thus af-
fecting Drosha and/or Dicer interaction with pri-miRNA or pre-miRNA.
More importantly, deregulation of RBPs expression and activity has
been linked to several malignancies. Among the panel of factors iden-
tiﬁed for example: DDX1, BRCA, ARS2, DR5, ADAR1, hRNP A1, KSRP,
Lin 28, SMADs, YAP, ERα, ERβ, wtp53 and mutant p53 [79,80]. Of
note, included in this list of RBPs, there are few DNA damage response
(DDR) proteins [81].
Remarkably, several groups pointed to a speciﬁc miRNA-RBP in-
terplay in response to external stimuli including DNA damage. Diﬀerent
enzymes involved in DDR have been shown to participate in miRNA
processing and maturation (Fig. 4). Up-regulation of speciﬁc miRNAs
such as miR-16-1, miR-143, miR-206 and miR-145 has been shown to
be induced in a p53-dependent manner after DNA damage. p53 is able
to interact with the Drosha complex through p68 increasing pri-miRNA
biogenesis. Interestingly, transcriptionally inactive p53 mutants disrupt
G. Antoniali et al. DNA Repair 56 (2017) 65–74
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Drosha and p68 complex suppressing miRNA processing activity of
Drosha by sequestering p68 cofactor [79,82].
Additionally, BRCA1, a key player in DSBs (Double Strand Breaks)
response, has been recently shown to increase the expression of let-7a-
1, miR-16-1, miR-145, and miR-34a through a direct binding of p68
RNA helicase in Drosha complex [83].
ATM, a crucial kinase in DDR, regulates miRNA expression in re-
sponse to DNA damage through the phosphorylation of diﬀerent targets
including, KSPR [84], p53 [84,85], ΔNp63α [86] and BRCA1 by in-
directly promoting the processing of a subset of pri-miRNAs [83].
MMR pathway can also mediate miRNA processing. The hetero-
dimer MLH1-PMS2 (MutLα) has been shown to positively regulate the
processing of miR-422a and other miRNAs by speciﬁcally stimulating
the Drosha/DGCR8-catalyzed processing of pri-miRNAs to pre-miRNAs
[87].
Diﬀerent studies have also suggested a possible involvement of BER
proteins in miRNA processing, particularly those proteins found to be
multifunctional enzyme with unique features such as: YB-1, Poly(ADP-
ribose) polymerases (PARPs) and APE1.
YB-1 is a multifunctional protein participating in a variety of DNA/
RNA-dependent events such as DNA replication and RNA-processing
events including mRNA transcription, splicing, translation and stability.
Interestingly, in light of its interaction with diﬀerent DNA repair en-
zymes, it is considered as a non-canonical BER protein [88]. In addition,
genome-wide analysis of YB-1-RNA interaction in glioblastoma cell line
unraveled a novel role of YB-1 in the regulation of miRNA biogenesis
during tumorigenesis. Wu et al., recently demonstrated that YB-1 in-
teraction with the loop region of pre- and pri-miR-29b-2 interferes with
Drosha and Dicer cleavage step. Interestingly, down-regulation of miR-
29b-2 expression as a consequence of this missed recruitment of Drosha
and Dicer to miR-29b-2 precursor due to YB-1 blockage, has crucial
implication in glioblastoma proliferation [89].
Recent data suggest that miRNA biogenesis can be also modulated
by post-translational modiﬁcations of each member of the Argonaute
family by PARPs [90,91]. Indeed, poly(ADP-ribose) modiﬁcation of key
RNA regulatory proteins has been documented for every step of RNA
metabolism including miRNA biogenesis. There are ﬁve speciﬁc PARPs
that can be considered RBPs because of the presence of RNA binding
domain in their sequence (i.e. CCCH zing ﬁnger and RRMs, RNA re-
cognition motif): PARP7, PARP12, PARP13, PARP10 and PARP14. In
particular, it has been observed that, upon stress condition, an in-
creased PARP13 activity near the Argonaute/miRNA complex might
result in the disruption of the electrostatic interaction between miRNA
and its mRNA target with a consequent mRNA cleavage relief [91].
APE1 possible involvement in miRNA biogenesis was previously
only speculative based on diﬀerent ﬁndings. It has been demonstrated
that APE1 can directly bind, in vitro, structured RNA molecules through
its 33 amino acids N-terminal domain [92] and, more interestingly, that
APE1 is endowed with RNA-processing activity over single-stranded
RNA, regulating for example c-Myc mRNA level and half-life in tumor
cells [93] and, of note, it can cleave pre-miR10b and pre-miR-21 in-
terfering with Dicer processing in vitro [94]. In addition, to further
support APE1 involvement in RNA processing it has been also demon-
strated its 3′-RNA phosphatase and 3′-exoribonuclease activities [95].
As a supplementary indirect observation, it has been recently found
that APE1 down-regulation is associated with alteration in miRNAs
expression, which are involved in pathways relating to developmental
and regulation of cellular processes, cell signaling and cancer [96].
Very recently, in order to improve our knowledge on APE1 possible
involvement in miRNA maturation, by using a combination of diﬀerent
unbiased high-throughput approaches at the transcriptomic and pro-
teomic levels, we demonstrated that APE1 is involved in miRNome
regulation by acting on early phases of miRNAs processing (Antoniali
et al., submitted). We found more than 1000 APE1-bound RNA among
which many ncRNAs and notably pri-miRNAs that are directly bound
by APE1 in cancer cells. In particular, we showed that APE1 en-
donuclease activity over pri-miR-221/222 mediates the regulation of
the tumor suppressor PTEN, a known target of these miRNAs [97].
Moreover, we evidenced, for the ﬁrst time, that APE1 associates with
the Drosha microprocessor complex during oxidative stress suggesting a
possible contribution of APE1 in RNA-decay pathways controlling
miRNAs precursors stability in the genotoxic cell response. Therefore,
since APE1 is an interacting partner of Drosha and of p53 [98] and
hRNPA1 (Antoniali et al., submitted), both proteins described as
modulator of Drosha-mediated cleavage, we may speculate that APE1
endoribonuclease activity is part of inducible mechanisms regulating
Fig. 4. Is BER involved in miRNA processing?
Regulation of miRNA biogenesis pathway by DNA damage response (DDR) proteins. Several DNA repair enzymes inﬂuence the processing of a subset of miRNA by recognizing speciﬁc
miRNA features or by associating with key components of the miRNA maturation pathway. Red boxes indicate DDR proteins involved in miRNA biogenesis.
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the processing of miRNA biogenesis in the nucleus especially during
oxidative stress or genotoxic damage. This is further support by the
observation that oxidative stress promotes APE1/Drosha interaction
and that APE1-kd is associated to increase oxidation levels of precursors
miRNAs. These ﬁndings, together with previous data that APE1 silen-
cing is associated with increased RNA oxidation [99], would support a
major role of APE1 in the RNA-decay mechanisms of precursors pri-
miRNAs.
Of note, not only RNA-binding factors can inﬂuence miRNA pro-
cessing, but also post-transcriptional modiﬁcation such as RNA-editing
may change both maturation and expression of miRNAs. Adenosine to
inosine (A-to-I) RNA-editing within the hairpin region of miRNA pre-
cursors is among the major eﬀective mechanism described to alter the
primary sequence of RNA. A-to-I miRNA editing is mediated by ade-
nosine deaminases acting on RNA (ADAR) protein, ADAR1 and ADAR2,
having consequences in miRNA biogenesis both at the level of Drosha
and Dicer [100]. Recently, Wang et al. demonstrated that also oxidation
represents another miRNA post-transcriptional modiﬁcation with re-
markably pathological outcomes. They proposed a new model in which
ROS may modulate cellular events by oxidatively modifying miRNAs, as
in the case of miR-184, which after oxidation changed its binding
proprieties from native targets to new ones [101].
In light of our previous data, demonstrating that APE1 has en-
doribonuclease activity over abasic RNA [99], we should therefore re-
interpret the roles of APE1 in modulating cellular responses to geno-
toxic stresses and in the pathogenesis of human diseases, taking into
account the new role of this multifunctional protein in RNA biology.
Our data demonstrate that APE1 is involved in speciﬁc miRNA pro-
cessing and highlight a new mechanism of miRNA regulation with
profound relevance in tumor biology.
In conclusion, recent advances in miRNA maturation pathways have
demonstrated that the multiple stages of miRNA biogenesis could serve
a multitude of regulatory options in control of miRNA-dependent gene
regulation. These ﬁndings have changed the conventional concept of
miRNA processing and have shown an additional level of complexity in
the miRNA network. miRNAs are often deregulated in human pathol-
ogies including cancer; frequently this change is a consequence of im-
paired transcription rate and/or miRNA processing. RBPs and their
interacting modulators mostly account for these observed changes in
miRNAs processing and activity.
Further investigations on the additional mechanisms that control
the processing of miRNAs under various cellular conditions and the role
of DNA repair proteins will extend our knowledge on miRNA function
in both physiological and pathological processes. These ﬁndings will
also oﬀer a molecular basis for diagnostic and therapeutic strategies
based on miRNA biology.
6. New insights about BER involvement into removal of modiﬁed
ribonucleotides embedded in DNA
A “new type of damage”, abundantly explored in the very last years,
is the presence of ribonucleotides monophosphate (rNMPs) within
genomic DNA. It has been studied how the additional presence of a
reactive 2′-hydroxyl group on the sugar ring may: i) alter the DNA
physical properties, reducing its elasticity [102,103] and structure in a
sequence dependent manner [104–108]; ii) induce DNA replication or
transcription arrest making the DNA backbone prone to hydrolysis
triggering a persistent genomic instability [103,108,109]. This in-
corporation occurs quite frequently into the cell [110,111], potentially
during every DNA replication reaction [110]. It has been estimated that
a few thousands of rNMPs are embedded in budding yeast genome
[110] and over a million in mouse genome [112]. The higher amount of
the cellular pool of ribonucleotides (rNTPs), compared to their corre-
sponding deoxyribonucleotides (dNTPs) [110] counterparts, combined
to an incomplete elimination of RNA primers used in the generation of
Okazaki fragments [113] and an imprecise 3′-exonucleolytic
proofreading activity of replicative DNA polymerases [113–117] are
some of the major causes of the rNMPs incorporation into genomic
DNA. Moreover, another potential signiﬁcant, yet poorly characterized,
source of rNMPs incorporated in DNA is oxidative stress. Speciﬁcally,
ROS, among which the hydroxyl radical ‘OH is the most reactive, can
attack all components of DNA, including the deoxyribose giving rise to
ribose [118], both in vitro and in vivo. Moreover, oxidation can occur
not only in DNA but also in the nucleotides pool and then rNMP may be
incorporated into neo-replicated DNA. During last years, several ap-
proaches have been developed [119], including Ribose-seq, in order to
map rNMPs sites into genomic DNA [111]. By using these methods, it
has been discovered that the incorporation of rNMPs has a widespread
but not random distribution in chromosomal DNA of budding and ﬁs-
sion yeast [111] and their number, per nuclear chromosome, seems to
be proportional to the chromosome size [111].
It is imperative that mis-incorporated rNMPs should be eﬃciently
and rapidly repaired by the cell, otherwise the eﬀect on genome sta-
bility and cell survival can be disastrous. Processing of single rNMPs
embedded in DNA is guided by the Ribonucleotide Excision Repair
(RER) pathway in which the leading initiating enzyme is RNase H2
[120] deputed to incise the phosphodiester linkage at 5′ end of rNMPs
[121]. Conditions in which human RNASEH2 is mutated, are associated
with a neurological auto-inﬂammatory childhood disorder named Ai-
cardi-Goutières Syndrome (AGS), characterized by an over production
of IFNγ [122–124]. It has been demonstrated that AGS patients, having
altered RNase H2 activity, may accumulate rNMPs in DNA, which could
induce a chronic, low-level DNA damage response signaling that sti-
mulates innate immune pathways [125]. Moreover, RNase H2-null
murine embryonic ﬁbroblasts (MEFs) accumulate over 1 million rNMPs
in their genomic DNA, activating a p53-dependent damage response,
whereas null-RNase H2 are embryonic lethal [121]. While, under
normal physiologic conditions, the involvement of functional RER
pathway in repairing the rNMPs incorporated in DNA is known
[112,120] information is scanty about possible back-up mechanisms,
provided by other DNA-repair pathways, when RER is functionally
impaired. In the absence of RNase H2, Topoisomerase I cleavage [126]
followed by nick processing by Srs2–Exo1 can remove some rNMPs
[127,128]. Paired and mispaired rNMPs in DNA can also be targeted by
the nucleotide excision repair (NER) in bacteria [129] but likely not in
mammalian cells [130], and by the mismatch repair (MMR) systems
[131,132]. About this last pathway, it was hypothesized the in-
corporation of ribonucleotides into mismatching damaged DNA could
be interpreted as a putative “beneﬁc” role, veriﬁable in a signal for the
activation of MMR pathway [133].
However, nothing is currently known about the mechanisms, if any,
responsible for repairing modiﬁed rNMPs embedded in DNA such as
abasic or oxidized rNMPs. Future studies are required to address this
issue.
7. Open questions and future perspectives
Based on the observations described so far, many open questions
remain to be addressed:
• Considering that many BER enzymes are catalytically active in many
diﬀerent RNA substrates, are their main functions linked to RNA-
decay processes or in the editing processes?
• May the role of BER enzymes, both mRNA and ncRNA, aﬀect the
protein translational machinery thus contributing to gene expres-
sion regulation through post-transcriptional mechanisms?
• It is unknown whether abasic RNA may derive from enzymatic
processing of modiﬁed (i.e. oxidized, alkylated) RNA. Are there
speciﬁc BER glycosylases responsible for recognition and processing
of these substrates?
• Is the BER involved in processing modiﬁed ribonucleotides em-
bedded in human genome, which are not repaired through canonical
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RER?
• Based on the emerging role of 8-oxoG as a new epigenetic mark, do
BER proteins work as novel epigenetic regulators?
• Pondering the many evidences about the relevance of non-canonical
function of BER proteins, should we reinterpret the overall biolo-
gical function of BER and their role in cancer and neurodegenera-
tion?
Answer to these questions may help us to better understand the role
of BER pathway in diﬀerent pathological processes from neurodegen-
eration to cancer development moving from an old tolemaic and re-
ductive vision, which considers BER only a mere DNA repair pathway,
to a more galileian theory which regards also its essential function in
RNA biology and thus may explain its unpredicted role in gene ex-
pression.
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